Investment case
Teladoc Health, Inc.
TDOC · 4 developments mapped · last assessed 2026-09-25
Market Ontology has mapped 4 macro, policy, and market developments to Teladoc Health, Inc. since 2026-09-01. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for TDOC yet, so no modelled value is shown. The TDOC valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run TDOC on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
NexLife Launches Flat-Rate $119-$169 Compounded GLP-1 Programs Across Doses
Increased demand for telehealth services to access and manage GLP-1 prescriptions, particularly for lower-cost compounded options that often rely on virtual care models.
· Moves subscriber growth, utilization rates of virtual care services, average revenue per user (arpu)
- Open question
NexLife Expands Compounded GLP-1 Plans With Flat $119-$169 Monthly Tiers
Increased competition in the telehealth-enabled GLP-1 weight management space, potentially impacting pricing or market share for existing programs, but also validating the telehealth model for GLP-1s.
· Moves growth rate of chronic care programs, customer acquisition costs
What changed, by assumption
- 2026-09-01NexLife Launches Flat-Rate $119-$169 Compounded GLP-1 Programs Across Doses
- 2026-09-01NexLife Expands Compounded GLP-1 Pricing at $119-$169 Flat Monthly Fee
- 2026-09-01NexLife Expands Compounded GLP-1 Plans With Flat $119-$169 Monthly Tiers
- 2026-09-25Teladoc Health, Inc. Announces Resignation of Chief Legal Officer Adam C. Vandervoort
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-25 | Teladoc Health, Inc. Announces Resignation of Chief Legal Officer Adam C. Vandervoort | watch | 1-3m | 0.20 |
| 2026-09-01 | NexLife Expands Compounded GLP-1 Pricing at $119-$169 Flat Monthly Fee | Bullish | 1-3m | 0.60 |
| 2026-09-01 | NexLife Expands Compounded GLP-1 Plans With Flat $119-$169 Monthly Tiers | mixed | 3-12m | 0.40 |
| 2026-09-01 | NexLife Launches Flat-Rate $119-$169 Compounded GLP-1 Programs Across Doses | Bullish | 1-3m | 0.70 |